Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$221.17
-0.6%
$237.59
$146.12
$251.71
$535.63B0.277.86 million shs5.46 million shs
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$111.26
-0.9%
$117.07
$73.31
$125.14
$277.36B0.189.56 million shs5.71 million shs
Novartis AG stock logo
NVS
Novartis
$145.98
+0.4%
$153.19
$104.93
$170.46
$277.43B0.461.36 million shs1.07 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.65
-3.1%
$27.14
$21.97
$28.75
$146.36B0.3536.09 million shs37.42 million shs
Roche Holding AG stock logo
RHHBY
Roche
$51.09
+1.0%
$51.58
$35.07
$60.85
$322.25B0.51.98 million shs1.51 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.00%-3.38%-7.73%-7.46%+41.43%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.00%+2.65%-8.95%-7.95%+41.89%
Novartis AG stock logo
NVS
Novartis
0.00%-1.73%-5.78%-7.01%+30.09%
Pfizer Inc. stock logo
PFE
Pfizer
0.00%-1.00%-3.62%-2.80%+16.24%
Roche Holding AG stock logo
RHHBY
Roche
0.00%-0.58%+1.01%-12.33%+25.43%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$221.17
-0.6%
$237.59
$146.12
$251.71
$535.63B0.277.86 million shs5.46 million shs
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$111.26
-0.9%
$117.07
$73.31
$125.14
$277.36B0.189.56 million shs5.71 million shs
Novartis AG stock logo
NVS
Novartis
$145.98
+0.4%
$153.19
$104.93
$170.46
$277.43B0.461.36 million shs1.07 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.65
-3.1%
$27.14
$21.97
$28.75
$146.36B0.3536.09 million shs37.42 million shs
Roche Holding AG stock logo
RHHBY
Roche
$51.09
+1.0%
$51.58
$35.07
$60.85
$322.25B0.51.98 million shs1.51 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.00%-3.38%-7.73%-7.46%+41.43%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.00%+2.65%-8.95%-7.95%+41.89%
Novartis AG stock logo
NVS
Novartis
0.00%-1.73%-5.78%-7.01%+30.09%
Pfizer Inc. stock logo
PFE
Pfizer
0.00%-1.00%-3.62%-2.80%+16.24%
Roche Holding AG stock logo
RHHBY
Roche
0.00%-0.58%+1.01%-12.33%+25.43%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.67
Moderate Buy$252.4814.15% Upside
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
2.68
Moderate Buy$128.1815.21% Upside
Novartis AG stock logo
NVS
Novartis
2.31
Hold$141.20-3.28% Downside
Pfizer Inc. stock logo
PFE
Pfizer
2.23
Hold$28.7412.05% Upside
Roche Holding AG stock logo
RHHBY
Roche
2.45
Hold$51.500.80% Upside

Current Analyst Ratings Breakdown

Latest RHHBY, JNJ, MRK, NVS, and PFE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
UpgradeHold (C-)Hold (C)
5/6/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Initiated CoverageNeutral$125.00
5/1/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Reiterated RatingHold (C+)
5/1/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Lower Price TargetOverweight$150.00 ➝ $145.00
4/29/2026
Novartis AG stock logo
NVS
Novartis
DowngradeBuy (A-)Buy (B)
4/29/2026
Pfizer Inc. stock logo
PFE
Pfizer
Boost Price TargetNeutral$26.00 ➝ $27.00
4/24/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
DowngradeBuy (B+)Buy (B)
4/24/2026
Roche Holding AG stock logo
RHHBY
Roche
UpgradeUnderweightEqual Weight$46.00
4/20/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Boost Price TargetBuy$244.00 ➝ $266.00
4/20/2026
Pfizer Inc. stock logo
PFE
Pfizer
Reiterated RatingUnderperform$25.00
4/16/2026
Pfizer Inc. stock logo
PFE
Pfizer
Initiated CoverageOutperform$33.00
(Data available from 5/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$94.19B5.65$14.03 per share15.76$33.73 per share6.56
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$65.01B4.23$11.32 per share9.83$18.60 per share5.98
Novartis AG stock logo
NVS
Novartis
$54.53B5.11$10.78 per share13.54$20.40 per share7.16
Pfizer Inc. stock logo
PFE
Pfizer
$62.58B2.34$4.26 per share6.02$15.86 per share1.62
Roche Holding AG stock logo
RHHBY
Roche
$76.45B4.26$3.64 per share14.05$7.18 per share7.12
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$26.80B$8.6525.5717.582.1821.83%32.60%13.29%7/15/2026 (Estimated)
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$18.25B$3.5531.3411.392.5313.59%27.55%10.73%N/A
Novartis AG stock logo
NVS
Novartis
$13.98B$6.9820.9114.852.5524.87%38.82%15.16%7/21/2026 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$7.77B$1.3119.588.97N/A11.83%19.44%8.41%N/A
Roche Holding AG stock logo
RHHBY
Roche
$15.55BN/AN/A14.564.16N/AN/AN/A7/23/2026 (Estimated)

Latest RHHBY, JNJ, MRK, NVS, and PFE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/5/2026Q1 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.7220$0.75+$0.0280$0.47$13.84 billion$14.45 billion
4/30/2026Q1 2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
-$1.47-$1.28+$0.19-$1.72$15.85 billion$16.29 billion
4/27/2026Q1 2026
Novartis AG stock logo
NVS
Novartis
$2.11$1.99-$0.12$1.65$13.44 billion$13.52 billion
4/14/2026Q1 2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.68$2.70+$0.02$2.14$23.60 billion$24.06 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.202.35%+5.25%60.12%64 Years
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$3.403.06%+5.75%95.77%14 Years
Novartis AG stock logo
NVS
Novartis
$3.082.11%+5.28%44.13%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.71%-13.20%131.30%16 Years
Roche Holding AG stock logo
RHHBY
Roche
$0.971.90%N/AN/AN/A

Latest RHHBY, JNJ, MRK, NVS, and PFE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/22/2026
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.436.71%5/8/20265/8/20266/12/2026
4/14/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.342.23%5/26/20265/26/20266/9/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.46
1.03
0.77
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
1.02
1.30
1.30
Novartis AG stock logo
NVS
Novartis
0.96
0.85
0.65
Pfizer Inc. stock logo
PFE
Pfizer
0.67
1.25
0.87
Roche Holding AG stock logo
RHHBY
Roche
0.72
1.38
1.12

Institutional Ownership

CompanyInstitutional Ownership
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
76.07%
Novartis AG stock logo
NVS
Novartis
13.12%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
Roche Holding AG stock logo
RHHBY
Roche
N/A

Insider Ownership

CompanyInsider Ownership
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.17%
Novartis AG stock logo
NVS
Novartis
0.01%
Pfizer Inc. stock logo
PFE
Pfizer
0.62%
Roche Holding AG stock logo
RHHBY
Roche
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,2002.41 billion2.40 billionOptionable
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
75,0002.47 billion2.47 billionOptionable
Novartis AG stock logo
NVS
Novartis
75,2671.91 billion1.91 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
75,0005.70 billion5.66 billionOptionable
Roche Holding AG stock logo
RHHBY
Roche
103,2496.37 billionN/ANot Optionable

Recent News About These Companies

Roche Q1 sales down on forex effects

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$221.17 -1.34 (-0.60%)
Closing price 05/8/2026 03:59 PM Eastern
Extended Trading
$221.25 +0.08 (+0.04%)
As of 05/8/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Merck & Co., Inc. stock logo

Merck & Co., Inc. NYSE:MRK

$111.26 -1.05 (-0.93%)
Closing price 05/8/2026 03:59 PM Eastern
Extended Trading
$111.84 +0.59 (+0.53%)
As of 05/8/2026 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Novartis stock logo

Novartis NYSE:NVS

$145.98 +0.59 (+0.41%)
Closing price 05/8/2026 03:59 PM Eastern
Extended Trading
$146.20 +0.22 (+0.15%)
As of 05/8/2026 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

Pfizer stock logo

Pfizer NYSE:PFE

$25.65 -0.83 (-3.15%)
Closing price 05/8/2026 03:59 PM Eastern
Extended Trading
$25.68 +0.03 (+0.11%)
As of 05/8/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Roche stock logo

Roche OTCMKTS:RHHBY

$51.09 +0.51 (+1.00%)
As of 05/8/2026 04:00 PM Eastern

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.